Loading...

Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma

BACKGROUND: The combination of nivolumab and ipilimumab is approved in several jurisdictions (United States, European Union, Canada) for the first-line treatment of patients with advanced melanoma. CheckMate 218 is a North American expanded-access program (eap) of nivolumab plus ipilimumab in patien...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Hogg, D., Monzon, J.G., Ernst, S., Song, X., McWhirter, E., Savage, K.J., Skinn, B., Romeyer, F., Smylie, M.
Format: Artigo
Sprog:Inglês
Udgivet: Multimed Inc. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467793/
https://ncbi.nlm.nih.gov/pubmed/32905202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5985
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!